Evidence map›Paper›PMID 21309061›Full record

ArticleDiabetes/metabolism research and reviews2011

Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans.

K A Han, Y Patel, A A Lteif, R Chisholm, Kieren J Mather

Open access · greenAbstract read
In one paragraph

Article in Diabetes/metabolism research and reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. The vascular endothelium in diabetes--a therapeutic target?Reviews in endocrine & metabolic disorders · 2013
    Review
  12. Role of insulin resistance in endothelial dysfunction.Reviews in endocrine & metabolic disorders · 2013
    Review
  13. Article
  14. Article
  15. Heart of the matter: coronary dysfunction in metabolic syndrome.Journal of molecular and cellular cardiology · 2012
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

K A HanDivision of Endocrinology & Metabolism, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Y Patel
A A Lteif
R Chisholm
Kieren J Mather
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSIONM01RR000750 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI STORNIOLO, ANNA · 1985 to 2008
$25.5M
ROLE OF HEMODYNAMICS IN IN VIVO INSULIN RESISTANCER37DK042469 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MATHER, KIEREN J · 1999 to 2003
$1.1M
ROLE OF HEMODYNAMICS IN IN VIVO INSULIN RESISTANCER01DK042469 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BARON, ALAIN D · 1995 to 1998
–
ROLE OF HEMODYNAMICS IN IN VIVO INSULIN RESISTANCER29DK042469 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BARON, ALAIN D · 1990 to 1994
–
NCRR NIH HHS M01 RR000750NCRR NIH HHS M01 RR00750NIDDK NIH HHS DK 42469NIDDK NIH HHS R37 DK042469
6 · The paper itself

Abstract

backgroundIndividual effects of hyperglycaemia and obesity to impair vascular health are recognized. However, the relative contributions of dysglycaemia versus other obesity-related traits to vascular dysfunction have not been systematically evaluated.

methodsWe undertook a cross-sectional evaluation of factors contributing to vascular function in 271 consecutive subjects, categorized as non-obese normal glucose tolerant (n = 115), non-obese dysglycaemic (n = 32), obese normal glucose tolerant (n = 57), obese dysglycaemic (n = 38), or type 2 diabetic (n = 29). Vascular function was measured invasively as leg blood flow responses to methacholine chloride, an endothelium-dependent vasodilator. Categorical and continuous analyses were carried out to assess the contributions of hyperglycaemia to vascular dysfunction.

resultsEven among normoglycaemic subjects, obese subjects had impaired vascular function compared to non-obese subjects (p = 0.004). Vascular function was also impaired in non-obese dysglycaemic subjects (p = 0.04 versus non-obese normoglycaemic subjects), to a level comparable to normoglycaemic obese subjects. Within obese subject groups, gradations of dysglycaemia including the presence of diabetes were not associated with further worsening of these vascular responses beyond the effect of obesity alone (p = not significant comparing all obese groups, p < 0.001 versus lean normoglycaemic subjects). After univariate and multivariable modelling analyses we found that effects of glycaemia were less powerful than effects of insulin resistance and obesity on vascular dysfunction.

conclusionsDysglycaemia contributes to impaired vascular function in non-obese subjects, but obesity and insulin resistance are more important determinants of vascular function in obese and diabetic subjects.

Indexed as

Insulin ResistanceVasodilationAdultBody Mass IndexCross-Sectional StudiesDiabetes Mellitus, Type 2Endothelium, VascularFemaleHumansHyperglycemiaLegMaleMethacholine ChlorideObesityPrediabetic StateRegional Blood FlowMethacholine ChlorideVasodilator Agents

Identifiers

PMID21309061
PMCPMC3090665
OpenAlexW2131146351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.